In my role as immediate Past President of the International Atherosclerosis Society, I wish to welcome you to the International Atherosclerosis Society Anitschkow Days meeting to be held in St Petersburg, Russia on 2-4 June 2016.
This is the latest in a long list of highly successful International Atherosclerosis Society meetings that have been held over the past 40 years. I am sure that it will not be the last.
The theme of the meeting is both topical and important, with a great program that includes presentations from eminent clinicians and researchers of high international standing.
Please enjoy what will undoubtedly be a major educational event.
Professor Philip Barter
Immediate Past President of the International Atherosclerosis Society
This is a great honour for me to invite you for active participation at the Symposium of the International Atherosclerosis Society “Anitschkow Days” to be held in St. Petersburg, Russian Federation on June 2–4, 2016.
The choice of St. Petersburg as the hosting city reflects the significant impact provided by Russian scientists to the development of atherosclerosis research in the 20th century. Nikolay Anitschkow was the one who discovered the lipid nature of atherosclerosis and Anatoly Klimov was the first to investigate an autoimmune theory.
This symposium will create a new opportunity to develop cooperation between the International Atherosclerosis Society and the Russian Society of Cardiology. We are facing mutual global cardiovascular challenges and have to work out new effective solutions. The voices of our societies are of exceptional importance in this respect.
An exchange of ideas and practical collaboration in cardiology, as well in healthcare management and social activities seem to be a good basis for future achievements. We have achieved a high level of mutual understanding which I hope will lead to further progress in decrease of cardiovascular morbidity and mortality.
Moreover, new perspectives now opening in applying molecular insights from a laboratory into a clinical setting are obviously giving a new impact to cooperation both in basic and clinical research embracing translational medicine as a 21st century way to optimize patient care and preventive measures.
Welcome to St. Petersburg, a beautiful city with a worldwide fame for its architectural ensembles, parks, museums and the white nights!
With best regards
Professor Evgeny Shlyakhto, MD, PhD, FESC, FACC
President of the Russian Society of Cardiology
Dear colleagues and friends!
Welcome to the new era of lipids and atherosclerosis! It is my great honor to invite you to the Symposium, IAS 2016 – Anitschkow Days – which is to be held in St. Petersburg. Why is this event so important? We are witnessing a breakthrough in the fields of prevention of cardiovascular diseases, atherosclerosis and clinical lipidology. Allow me, briefly, to describe the situation. Clinical medicine, and research connected with atherosclerosis and lipids, were strongly connected with the statin success story the last twenty years and we did not expect any significant movement forward. However, the times are a-changing!
Nowadays, we are facing new treatment methods, based on totally new principles of action, many of which require new, parenteral applications with modern devices and, above all, capable of reaching unbelievable targets of LDL-C and other lipids. We can influence Lp/a/ and other lipid parameters. At the same time, we can follow results of interventional trials, document the prevention of cardiovascular diseases with hyperlipoproteinemia and dyslipidemia treatment. In addition, research in the field of atherosclerosis and lipid disorders is rapidly developing and new methods of molecular biology are becoming “the routine”
(e.g. “new generation testing” for familial hypercholesterolemia). All these aspects will be covered by the IAS 2016, but the organizing committee is placing great emphasis on clinical practice of preventive cardiology and clinical lipidology.
It is crucial that these new achievements be discussed in St. Petersburg, the city where the cholesterol hypothesis was born more than 100 years ago. A city where the West meets the East. The beauty and historic cultural tradition of the former capital of Russia will support collaboration (old as well as new) between physicians from countries all over the world.
On behalf of the organizing committee I would like to promise that we will do our best to prepare an interesting program. I believe you will also find the time to meet with colleagues to discuss topics of your interest.
We are looking forward to seeing you in St. Petersburg at IAS 2016.
Richard Ceska, MD, PhD, FACP, FEFIM
Professor of Internal Medicine
Charles University and University Hospital Prague, Czech Republic
Chair of the Organizing Committee